Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity.
about
The good and evil of complement activation in HIV-1 infectionEffect of human immunodeficiency virus infection on plasma bactericidal activity against Salmonella enterica serovar Typhimurium.Role of mannose-binding lectin deficiency in HIV-1 and schistosoma infections in a rural adult population in Zimbabwe.Follicular Dendritic Cells Retain Infectious HIV in Cycling Endosomes.B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells.Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linkedComplement activation by human monoclonal antibodies to human immunodeficiency virus.Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21).Humoral immunity to HIV-1: neutralization and beyond.Immunoglobulin and complement complexes in blood following infection with human immunodeficiency virus type 1.Soluble membrane attack complex in the blood and cerebrospinal fluid of HIV-infected individuals, relationship to HIV RNA, and comparison with HIV negatives.Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate.Regulation of C3 deposition on gp120 coated CD4 positive cells by decay accelerating factor and factor H.Changes in the levels of some acute-phase proteins in human immunodeficiency virus-1 infected patients, following interleukin-2 treatment.
P2860
Q28275986-48EA27C6-1707-4951-B0D1-8BFBF00926AEQ34701418-7786CFF3-2215-4E3F-8A83-CEDA9AF34998Q35241916-F746728E-87D6-48AF-A481-30E8316DEEDDQ35856793-37D60379-BB53-4388-ADD2-086E64B6ADEAQ36368837-06C43236-4664-4659-9322-70B5E378BE9FQ36540060-0A70CCEE-E78B-4F29-B454-B1B669F532A5Q36638803-175AF97E-E456-4E67-8F8D-DEBD9D9B2C10Q36645449-A8ED25AF-22FB-40AE-BE97-6EDD8D79D823Q36863847-CB01D50F-3A02-4F45-BEE9-C3741ECC00F2Q39810120-2C2B1DA8-26A2-492B-B736-DB3414E0FAF9Q40095691-663159D5-7B46-46CC-9EF2-D01A476B5558Q40510073-5317A061-B7F8-4734-ABA0-3CBA0293CA81Q41425849-CC76BCDF-F251-4D60-AF8C-77406EBDDD16Q45376634-41CF3F00-B5F9-4F4D-A747-2B1F583A2DED
P2860
Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Activation of the complement s ...... ogenesis and disease severity.
@en
Activation of the complement s ...... ogenesis and disease severity.
@nl
type
label
Activation of the complement s ...... ogenesis and disease severity.
@en
Activation of the complement s ...... ogenesis and disease severity.
@nl
prefLabel
Activation of the complement s ...... ogenesis and disease severity.
@en
Activation of the complement s ...... ogenesis and disease severity.
@nl
P2093
P356
P1476
Activation of the complement s ...... ogenesis and disease severity.
@en
P2093
P304
P356
10.1093/INFDIS/162.6.1227
P407
P577
1990-12-01T00:00:00Z